Having trouble reading this newsletter? Click here to see it in your browser.
You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe.
forward to a friend
8 September 2009
Current Partnering Newsletter

Dealmakers Newsletter Update - Sept 2009

Sponsored this month by:

Partnering Agreements in Diagnostics

The Partnering Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading companies.

  • Comprehensive directory of diagnostic deals since 2003
  • Diagnostic contract documents
  • Diagnostic agreement terms
  • Diagnostic agreement structure
  • Top diagnostic deals by value
  • Most active diagnostic dealmakers

More details and order


  • Editor's corner
  • In the news
  • NEW! Scorecard
  • NEW! Partnering roundup
  • Best practice articles
  • Forthcoming events
  • Latest business reports
  • On the move - latest updates

Editor's corner

We are about to enter the fall season of Partnering conferences. Currentpartnering will be present at them all - the following are our suggested must attend events: Pharmaceutical Strategic Alliances, Biotechnica, EuroBio, BioNetwork, BIO-Europe 2009, and TA Partnerships  - watch out for our logo and brochures!

August saw an understandable slowdown in partnering activity - with only  just 148  alliances and 11 M&A deals. Our Scorecards keep you up to date with deals and alliances as they are announced. Of megadeals, the Dainippon-Sepracor  acquisition stands out.

NEW! Our industry round-up and in the news sections are updated daily online, providing you with the latest trends from the world's most respected publishers and deal news direct from biopharma companies as they are announced.

Our publishing arm has been busy introducing new reports - here are just a few of the titles new to 2009 rush to buy before price rises in the fall:

All for now - enjoy the partnering conference season.

 

-- Steve Poile --


In the news

The following are just some of the deals involving bigpharma announced in the last few weeks:

Deals of note so far in September 2009:

  • Dainippon Sumitomo Pharma to buy Sepracor for $2.6 billion
  • Algeta signs global agreement with Bayer Schering Pharma for development and commercialization of Alpharadin for bone metastases
  • Bayer HealthCare acquires two dermatology product lines from SkinMedica
  • DxS in collaboration with BMS and ImClone to provide a K-RAS companion diagnostic for ERBITUX
  • PTC Therapeutics in drug discovery collaboration with Roche
  • Roche subsidiary to buy Lonza Singapore facility for up to $360 million

Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature


NEW! Partnering roundup

Just some of the articles picked up by Roundup during early September:

Follow Roundup online here


NEW: Scorecard

Updated today - September 8, 2009

Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.

Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month.

In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard.

 


New and updated reports

New report titles:

CurrentPartnering has published new titles:

Partnering Agreements in Diagnostics

Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements

  • Comprehensive directory of diagnostic deals since 2003
  • Diagnostic contract documents
  • Diagnostic agreement terms
  • Diagnostic agreement structure
  • Top diagnostic deals by value
  • Most active diagnostic dealmakers

More details and order

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics

The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies

  • Comprehensive directory of oncology deals since 2003
  • Oncology contract documents
  • Oncology agreement terms
  • Oncology agreement structure
  • Top oncology deals by value
  • Most active oncology dealmakers

More details and order

Option & Evaluation Agreements in Pharma and Biotech

The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies

More details and order

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

More details and order
 

Revised and updated reports:

CurrentPartnering has revised and updated its most popular reports:

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition

The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies

More details and order

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition

The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition

More details and order

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity

More details and order

New from Datamonitor:

Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape

Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines

More details and order


Best practice articles

Mining Experiential Knowledge At Partnering Events - Part 2

The targeted information which is transferred in order to serve the intended partnering objective, is only one part of the informational interaction. The other part is an informational “by-product” which is not intended in the first place, and which is activated by communication, questions on the side, small talk - more

Mining Experiential Knowledge At Partnering Events - Part 1

When business development executives attend a euroPLX meeting (or any other partnering conference for that matter) they experience a learning process - more

Business speed dating at BIOTECHNICA 2009

Developing new business contacts is often time-consuming and costly. For this reason BIOTECHNICA now offers an affordable and speedy way for individuals and companies to link up with potential customers, suppliers and business partners - more

Protecting Intellectual Property Rights: Are Small Firms Handicapped?

This paper studies the determinants of patent suits and settlements during 1978-1999 by linking information from the U.S. patent office, the federal courts and industry sources. We find that litigation risk is much higher for patents owned by individuals and firms with small patent portfolios - more

Lost property: The European patent system and why it doesn’t work

In this paper, Bruno van Pottelsberghe focuses on the performance of the patent regime, the consistency of rules across countries and global governance questions concerning international cooperation among patent offices which are of major importance for competitiveness and growth - more

Read all our partnering best practice articles.

 


Forthcoming events

Here are some of our suggested events for fall 2009:

BioPharm America 2009

San Francisco, CA, USA - September 16-18, 2009 - more details

Pharmaceutical Strategic Alliances 2009

New York City, NY, USA - September 21-23, 2009 - more details

8th Annual Portfolio Evaluation and Strategic Investment Decision-Making

Philadelphia, PA, USA - September 22-23, 2009 - more details

EuroBio 2009

Lille, France - September 23-25, 2009 - more details

BioNetwork 2009

Laguna Niguel, California, USA - October 5-7, 2009 - more details

9th MedTech Investing Europe Conference

London, United Kingdom - October 5-6, 2009 - more details

Biotechnica 2009

Hannover, Germany - October 6-8, 2009 - more details

BioEurope 2009

Vienna, Austria - November 2-4, 2009 - more details

Therapeutic Area Partnerships 2009

Boston, MA, USA - November 17-19, 2009 - more details

View our full events calendar


People on the move

The following people have been reported on the move during August/September 2009:

Tom Kassberg, Tom Brya, Ivana Magovcevic-Liebisch, Brian Best, Miki Stevens to name just a few

read more about the latest people on the move

If you have news about a business development executive who is on the move - let us know


Partnering resources

Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.

The following topic areas are available - updated regularly:

  • Partnering organizations
  • Financing organizations
  • Online Partnering
  • Weblogs
  • Mentoring/Networking
  • Checklists
  • Quotes
  • Software Tools
  • Library
  • Journals
  • Careers
  • Training/education
  • Other useful links
     

Missing something? Let us know and we will include all appropriate resources.

 


Contact us

Steve Poile, Editor

Web: http://www.CurrentPartnering.com

Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom

Tel: +44 7896 656732

Fax: +44 8703 305993

Email

 


Advertizing and sponsorship

CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.

or contact us to discuss your requirements.

 


About CurrentPartnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers

  • Reports
  • Articles
  • In the news
  • Networks
  • Scorecard
  • Events
  • On the move
  • Careers
  • Glossary
  • Resources
  • Advisers




Sponsored by:

Title




















CurrentPartnering reports

CurrentPartnering is a leading publisher of partnering business intelligence

Here is what our clients say about our reports:

The information you provide is excellent and we look forward to doing more business with you in the future.

...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...

- for a full list of our latest publications visit the website at: www.currentpartnering.com

In additon, we list of publishers reports - see full list.






This email was sent to [email address suppressed]
Click here to instantly unsubscribe.

Current Partnering is a registered company in the UK - number 5722617
Registered Office: Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Email: info@currentpartnering.com